UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Advancements in the Treatment of Homozygous Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis, 2022/08/01, Vol.29(8), pp.1125-1135

2022

Volltextzugriff (PDF)

Antisense oligonucleotides for atherosclerotic disease

Nature medicine, 2020-04, Vol.26 (4), p.471-472

2020

Volltextzugriff (PDF)

Recent advances in the management and implementation of care for familial hypercholesterolaemia

Pharmacological research, 2023-08, Vol.194, p.106857-106857, Article 106857

2023

Volltextzugriff (PDF)

A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency

Journal of lipid research, 2022-03, Vol.63 (3), p.100169-100169, Article 100169

2022

Volltextzugriff (PDF)

Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran

Journal of the American Heart Association, 2024-03, Vol.13 (6), p.e032031-e032031

2024

Volltextzugriff (PDF)

From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?

European heart journal, 2022-09, Vol.43 (34), p.3240-3242

2022

Volltextzugriff (PDF)

Deep Apolipoprotein Proteomics to Uncover Mechanisms of Coronary Disease Risk

Journal of the American College of Cardiology, 2017-02, Vol.69 (7), p.801-804

2017

Volltextzugriff (PDF)

Attitudes and Barriers to Lipoprotein(a) Testing: A Survey of Providers at the University of Pennsylvania Health System

Journal of clinical lipidology, 2024-07, Vol.18 (4), p.e487-e488

2024

Volltextzugriff (PDF)

Lipoprotein(a) and Oxidized Phospholipids

Journal of the American College of Cardiology, 2023-05, Vol.81 (18), p.1793-1796

2023

Volltextzugriff (PDF)

Lipoprotein(a): Mirroring Familial Hypercholesterolemia

Journal of clinical lipidology, 2023-07, Vol.17 (4), p.e10

2023

Volltextzugriff (PDF)

Advancements in the Treatment of Homozygous Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis, 2022, Vol.29 (8), p.1125-1135

2022

Volltextzugriff (PDF)

Advancements in the Treatment of Homozygous Familial Hypercholesterolemia

Journal of Atherosclerosis and Thrombosis, 2022, pp.RV17065

2022

Volltextzugriff (PDF)

Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime or Individual Perpetrators in Cardiovascular Disease?

Journal of the American College of Cardiology, 2023-05, Vol.81 (18), p.1793-1796

2023

Volltextzugriff (PDF)

Attitudes and barriers to lipoprotein(a) testing: A survey of providers at the University of Pennsylvania health system

Journal of clinical lipidology, 2024-08

2024

Volltextzugriff (PDF)

Genetic Testing Results in a Preventative Cardiology and Inherited Lipid Disorders Clinic

Journal of clinical lipidology, 2024-07, Vol.18 (4), p.e540-e540

2024

Volltextzugriff (PDF)

Severe Heterozygous Familial Hypercholesterolemia and Elevated Lipoprotein(a): A Double Whammy

Journal of clinical lipidology, 2023-07, Vol.17 (4), p.e8-e9

2023

Volltextzugriff (PDF)

Implementation of Flag, Identify, Network, Deliver (FIND FH) Machine Learning Algorithm: A Quality Improvement Initiative to Perform Targeted Screening for Familial Hypercholesterolemia within a Single Healthcare System

American journal of preventive cardiology, 2020-09, Vol.3, p.100065, Article 100065

2020

Volltextzugriff (PDF)

LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia

The journal of clinical endocrinology and metabolism, 2022-01, Vol.107 (1), p.e57-e70

2022

Volltextzugriff (PDF)

Real-world Experience of Inclisiran at the University of Pennsylvania Health Systems

Journal of clinical lipidology, 2024-07, Vol.18 (4), p.e491-e492

2024

Volltextzugriff (PDF)

Parkinson's disease and cancer risk: a systematic review and meta-analysis

Cancer causes & control, 2010-05, Vol.21 (5), p.697-707

2010

Volltextzugriff (PDF)

Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis

Current atherosclerosis reports, 2021-11, Vol.23 (11), p.72-72, Article 72

2021

Volltextzugriff (PDF)

Familial Partial Lipodystrophy Due to a Mutation in Pparg Resulting in Severe Hypertriglyceridemia, Hepatosteatosis and Insulin Resistance

Journal of clinical lipidology, 2020-07, Vol.14 (4), p.567-567

2020

Volltextzugriff (PDF)

Shift Work, Chronotype, and Melatonin Rhythm in Nurses

Cancer epidemiology, biomarkers & prevention, 2019-07, Vol.28 (7), p.1177-1186

2019

Volltextzugriff (PDF)

Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70

Circulation (New York, N.Y.), 2022-05, Vol.145 (18), p.1377-1386

2022

Volltextzugriff (PDF)

ASCVD Risk Reduction in Patients with Immune-Mediated Inflammatory Disease: A Retrospective Quality Assessment Study

Journal of clinical lipidology, 2024-07, Vol.18 (4), p.e510-e511

2024

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(51)
magazinearticle
(4)

Sprache

Englisch
(54)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Advancements in the Treatment of Homozygous Familial Hypercholesterolemia

Antisense oligonucleotides for atherosclerotic disease

Recent advances in the management and implementation of care for familial hypercholesterolaemia

A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency

Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran

From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?

Deep Apolipoprotein Proteomics to Uncover Mechanisms of Coronary Disease Risk

Attitudes and Barriers to Lipoprotein(a) Testing: A Survey of Providers at the University of Pennsylvania Health System

Lipoprotein(a) and Oxidized Phospholipids

Lipoprotein(a): Mirroring Familial Hypercholesterolemia

Advancements in the Treatment of Homozygous Familial Hypercholesterolemia

Advancements in the Treatment of Homozygous Familial Hypercholesterolemia

Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime or Individual Perpetrators in Cardiovascular Disease?

Attitudes and barriers to lipoprotein(a) testing: A survey of providers at the University of Pennsylvania health system

Genetic Testing Results in a Preventative Cardiology and Inherited Lipid Disorders Clinic

Severe Heterozygous Familial Hypercholesterolemia and Elevated Lipoprotein(a): A Double Whammy

Implementation of Flag, Identify, Network, Deliver (FIND FH) Machine Learning Algorithm: A Quality Improvement Initiative to Perform Targeted Screening for Familial Hypercholesterolemia within a Single Healthcare System

LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia

Real-world Experience of Inclisiran at the University of Pennsylvania Health Systems

Parkinson's disease and cancer risk: a systematic review and meta-analysis

Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis

Familial Partial Lipodystrophy Due to a Mutation in Pparg Resulting in Severe Hypertriglyceridemia, Hepatosteatosis and Insulin Resistance

Shift Work, Chronotype, and Melatonin Rhythm in Nurses

Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70

ASCVD Risk Reduction in Patients with Immune-Mediated Inflammatory Disease: A Retrospective Quality Assessment Study

Suchergebnisse filtern